Additionally, activation of the PD-1/PD-L1 pathway negatively affects the differentiation of effector T-cells (59), memory T-cells (60), regulatory T-cells (Treg), and exhausted T-cells (61), greatly reducing the effect of T-cells on tumor cells (60). The gene discussed is PDCD1; the disease is neoplasm.